Skip to Content
Merck
All Photos(1)

Key Documents

13239E

Centrisart® I centrifugal ultrafiltration unit

MWCO 10 kDa

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41104916
NACRES:
NB.24

material

polystyrene housing
polystyrene outer tube
polysulfone membrane

sterility

non-sterile

packaging

pack of 12 tubes

manufacturer/tradename

Sartorius 13239E

parameter

2000 × g max. force (fixed angle)
2500 × g max. force (swinging bucket)

filtration area

0.79 cm2

outer sample tube W × L

14 mm × 93 mm

tube size

~15 mL

working volume × concentrate volume

2.5 mL × 100

pore size

10 kDa MWCO

Looking for similar products? Visit Product Comparison Guide

General description

  • Centrisart® I centrifugal ultrafiltration unit is ideal for the separation of small-volume proteins from low molecular weight substances in biological samples.
  • The unit works in the direction opposite to centrifugal force which prevents premature filter blockage.
  • This versatile device is utilized in both fixed-angle or swinging-bucket rotors that hold standard 15 mL tubes.
  • The product is collected in the easily accessible floater insert tube.

Application

  • Protein removal from blood samples
  • Drug binding studies
  • Cleaning of liposomes (cell lysates)

Legal Information

Centrisart is a registered trademark of Sartorius Stedim Biotech GmbH

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Agnieszka Smolinska et al.
Analytical and bioanalytical chemistry, 403(4), 947-959 (2012-03-08)
Because cerebrospinal fluid (CSF) is the biofluid which interacts most closely with the central nervous system, it holds promise as a reporter of neurological disease, for example multiple sclerosis (MScl). To characterize the metabolomics profile of neuroinflammatory aspects of this
Wenyi Zheng et al.
Scientific reports, 10(1), 1274-1274 (2020-01-29)
Selenocompounds (SeCs) are promising therapeutic agents for a wide range of diseases including cancer. The treatment results are heterogeneous and dependent on both the chemical species and the concentration of SeCs. Moreover, the mechanisms of action are poorly revealed, which most

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service